Nexgen Arrays Overview
Founded
2013
Status
Private
Employees
5
Latest Deal Type
Grant
Latest Deal Amount
$374K
Investors
3
Nexgen Arrays General Information
Description
Developer of a diagnostic technology for detecting Ebola viruses. The company provides a molecular diagnostic platform that enables medical specialists to detect viral diseases such as Ebola, Lassa and Marburg.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Biotechnology
Primary Office
- 8 Saint Mary's Street
- Boston, MA 02215
- United States
+1 (617) 000-0000
Nexgen Arrays Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 01-Jan-2015 | $374K | Completed | Startup | ||
| 2. Grant | 30-Sep-2014 | 0000 | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Jan-2014 | Completed | Startup |
Nexgen Arrays Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| George Daaboul Ph.D | Co-Founder & Chief Scientific Officer | ||
| David Freedman Ph.D | Co-Founder & Chief Executive Officer |
Nexgen Arrays Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| MassChallenge | Accelerator/Incubator | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial